Showing all 2 results
Efavirenz ,Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Mega-Dose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles to ensure the absolute chemical survival of the moisture-sensitive Tenofovir and light-sensitive Efavirenz.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The NNRTI Anchor: The massive, highly lipophilic non-nucleoside payload required to force immediate, systemic viral suppression. Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression to reinforce the backbone. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg The Nucleotide Backbone: The heavy-hitting chain terminator required to completely halt viral DNA elongation. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hydroxypropyl Cellulose / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Surfactant / Heavy Film-Coating (Engineered utilizing High-Compression Bi-Layer Technology to fuse 1,100mg of active API into a single, aerodynamically shaped tablet that remains easy for patients to swallow, heavily coated to lock out destructive tropical humidity) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the moisture-sensitive Tenofovir.
Active Ingredient Strength Primary Clinical Function Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression with an exceptionally favorable safety profile. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg
(Eq. to 245 mg Tenofovir Disoproxil)The Nucleotide Backbone: The heavy-hitting reverse transcriptase inhibitor required to anchor the ARV regimen and prevent viral breakthrough. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Polymeric Film (Opadry) Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing dry-granulation and heavy film-coating to protect the API from atmospheric moisture, ensuring the massive 500mg active payload remains structurally intact and easily swallowable) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
